ENOV vs PRCT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ENOV

32.4
AI Score
VS
PRCT Wins

PRCT

38.4
AI Score

Investment Advisor Scores

ENOV

32score
Recommendation
EXTENDED

PRCT

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ENOV PRCT Winner
Forward P/E 4.6404 0 Tie
PEG Ratio 1.8989 0 Tie
Revenue Growth 3.2% 19.3% PRCT
Earnings Growth 153.1% 0.0% ENOV
Tradestie Score 32.4/100 38.4/100 PRCT
Profit Margin -48.0% -32.5% PRCT
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY ENOV

Relative Price Performance (Last 90 Days)

ENOV 1M: +15.4% · 3M: -25.4% PRCT 1M: +14.1% · 3M: +12.8%

Current Technical Phase

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.8 · Price: $21.08

PRCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.3 · Price: $19.96

Fundamentals Snapshot

Metric ENOV PRCT
Market Cap — —
Forward P/E 6.0 -17.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% -0.3%
EPS -19.23 -1.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PRCT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.